Orthofix | Investor Presentation Deck | 22 slides · page 11 of 22
The slide highlights a TTM revenue of $733M with a breakdown of 28% Bone Growth Therapies, 57% Spinal Implants/Biologics/Enabling Tech, and 15% Orthopedics, alongside an 83/17 US/OUS split.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
donut bullet paragraph source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.